Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. They invest in novel science and innovative approaches to bring promising drug candidates to patients and accelerate their progress by actively supporting young drug development companies to achieve clinical proof of concept with their lead programs. Droia has an in-house team of experts and drug development professionals who follow the portfolio companies closely and provide hands-on support. Droia invests in early financing rounds and incubates new companies.

Venture Capital

Droia Ventures

Janwillem Naesens

Stéphanie Philtjens

Kathleen Sonck

Alexander Depauw

Carmen Bravo

Nele Vandervoort

Willem-Jan Wollants

Guy Eelen

Javier Perales-Patón

An Steensels

Kris Nys

Athanasios Didangelos

Matthias Van Woensel

Sara Morren

Evelien Verdrengh

Lenny Van Steenhuyse

George Golumbeski

Matthias De Witte

Sebastian Bernales

Luc Dochez

The Droia Labs Team at Droia Ventures conducts cutting-edge scientific research and provides comprehensive laboratory support to advance the development of novel drug candidates. Comprising scientists, bioinformaticians, and research associates, the team collaborates closely with portfolio companies to design and execute experiments, analyze biological data, and validate therapeutic hypotheses, thereby accelerating the pathway to clinical proof of concept.

Droia Labs Team

Advisory Team

Leadership Team

Droia Labs Team

About

Team members

Other teams at Droia Ventures

Advisory Team

Leadership Team